Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Meningioma × Aminolevulinic Acid × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 14 Glioblastoma 4 Brain Neoplasms 3 Skin Diseases 2 Precancerous Conditions 2 Glioma 2 Skin Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Meningioma 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1

Interventions

Topotecan 1 Thrombectomy 1 Temozolomide 1 ONC206 1 Mn-PyC3A 1 Laser Speckle Contrast Imaging 1 Irinotecan 1 Fentanyl 1 Cyclophosphamide 1 Cerebral Angiography 1 Aminolevulinic Acid 1 90Y-octreotide, DOTA-Tyr(3)- 1 64Cu-SARTATE 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305470 2024-06-18

MEN-301

NX Development Corp

Phase 3 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡